Sana Biotechnology, Inc. (SANA) Financials

SANA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 565.3 million 277.8 million
2023-09-30 631.4 million 265.6 million
2023-06-30 707.1 million 352.1 million
2023-03-31 746.9 million 318.7 million

SANA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -66.0 million 7.9 million
2023-09-30 -65.8 million 9.0 million
2023-06-30 -60.4 million 9.8 million
2023-03-31 -81.4 million 8.8 million

SANA Net Income

No data available :(

SANA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 209.0 million - 104.1 million
2023-09-30 268.6 million - 96.9 million
2023-06-30 325.9 million - 113.1 million
2023-03-31 355.1 million - 114.5 million

SANA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 197.3 million
2023-09-30 200.5 million
2023-06-30 192.5 million
2023-03-31 191.2 million

SANA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 14.0 million 48.5 million 20.8 million -
2023-09-30 2.2 million 17.0 million 19.2 million -
2023-06-30 1.6 million 99.7 million 16.6 million -
2023-03-31 2.2 million 67.3 million 16.8 million -

SANA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 7.5 million
2023-09-30 - 4.5 million
2023-06-30 - 7.8 million
2023-03-31 - 7.7 million

SANA

Price: $9.63

52 week price:
2.75
12.00

Earnings Per Share: -1.46 USD

P/E Ratio: -4.37

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 1.2 million

Market Capitalization: 2.0 billion

Links: